These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 8858086

  • 1. New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
    Conrad DA, Jenson HB.
    Postgrad Med; 1996 Oct; 100(4):113-8, 121-5, 127. PubMed ID: 8858086
    [Abstract] [Full Text] [Related]

  • 2. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
    Lau CL, Streeton CL, David MC, Sly PD, Mills DJ.
    J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
    [Abstract] [Full Text] [Related]

  • 3. [Vaccines inf the prevention of fecal hazards].
    Saliou P.
    Bull Soc Pathol Exot; 1998 Feb; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.
    MMWR Recomm Rep; 1996 Nov 22; 45(RR-13):1-16. PubMed ID: 8965784
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.
    Lancet Infect Dis; 2014 Feb 22; 14(2):119-29. PubMed ID: 24290843
    [Abstract] [Full Text] [Related]

  • 13. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD.
    N Engl J Med; 2009 Jul 23; 361(4):335-44. PubMed ID: 19625715
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
    Overbosch D, Peyron F, Picot N, Varichon JP, Dumas R, Chambonneau L, Weber F.
    J Travel Med; 2005 Jul 23; 12(6):319-26. PubMed ID: 16343383
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R, Forrat R, Lang J, Farinelli T, Loutan L.
    Adv Ther; 1997 Jul 23; 14(4):160-7. PubMed ID: 10174195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.